Skip to main content
Erschienen in: Rheumatology International 4/2007

01.02.2007 | Original Article

Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis

verfasst von: Taciser Kaya, Serpil Bal, Rezzan Gunaydin

Erschienen in: Rheumatology International | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

In this study, we evaluated the relationship between the severity of enthesitis and outcome of measurement indices, clinical and laboratory parameters in patients with ankylosing spondylitis (AS). Thirty-three patients who fulfilled the modified New York criteria for AS were included in this study. Patients were asked to record the severity of current pain, night pain and morning stiffness on a 10-cm visual analogue scale. Stoke Enthesitis Index (SEI) was used to measure the severity of enthesitis. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI) were calculated. SEI was correlated positively only with BASDAI (= 0.370, = 0.034). There was no relation between SEI and laboratory parameters (Erythrocyte Sedimentation Rate and C Reactive Protein). Our data suggest that using an enthesitis index such as SEI can be a valuable tool in the evaluation of disease activity in patients with AS. However, evaluation of enthesitis severity is based on information given by patient and should be combined with objective parameters such as spinal measurements when assessing disease activity.
Literatur
1.
Zurück zum Zitat Calin A (1989) Ankylosing spondylitis. In: Kelley WN, Haris ED (eds) Textbook of rheumatology, 3rd edn. W. B. Saunders, Philadelphia, pp 1021–1037 Calin A (1989) Ankylosing spondylitis. In: Kelley WN, Haris ED (eds) Textbook of rheumatology, 3rd edn. W. B. Saunders, Philadelphia, pp 1021–1037
2.
Zurück zum Zitat Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127–132PubMedCrossRef Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewe R et al (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62(2):127–132PubMedCrossRef
3.
Zurück zum Zitat Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondylarthropathy at entheses and related sites. J Anat 199:503–526PubMedCrossRef Benjamin M, McGonagle D (2001) The anatomical basis for disease localisation in seronegative spondylarthropathy at entheses and related sites. J Anat 199:503–526PubMedCrossRef
4.
Zurück zum Zitat Drouart M, Saas P, Billot M et al (2003) High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 132(1):158–162PubMedCrossRef Drouart M, Saas P, Billot M et al (2003) High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 132(1):158–162PubMedCrossRef
5.
Zurück zum Zitat D’Agostino MA, Said-Nahal R, Hacquard-Bouder C et al (2003) Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48(2):523–533PubMedCrossRef D’Agostino MA, Said-Nahal R, Hacquard-Bouder C et al (2003) Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study. Arthritis Rheum 48(2):523–533PubMedCrossRef
6.
Zurück zum Zitat McGonagle D, Marzo-Ortega H, O’Connor P et al (2002) The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 46(2):489–493PubMedCrossRef McGonagle D, Marzo-Ortega H, O’Connor P et al (2002) The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy. Arthritis Rheum 46(2):489–493PubMedCrossRef
7.
Zurück zum Zitat Mander M, Simpson JM, McLellan A et al (1987) Studies with an enthesitis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197–202PubMed Mander M, Simpson JM, McLellan A et al (1987) Studies with an enthesitis index as a method of clinical assessment in ankylosing spondylitis. Ann Rheum Dis 46:197–202PubMed
8.
Zurück zum Zitat Davis JC Jr (2005) Ankylosing spondylitis. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. A textbook of rheumatology. Lippincott Williams and Wilkins, Philadelphia, pp 1319–1334 Davis JC Jr (2005) Ankylosing spondylitis. In: Koopman WJ, Moreland LW (eds) Arthritis and allied conditions. A textbook of rheumatology. Lippincott Williams and Wilkins, Philadelphia, pp 1319–1334
9.
Zurück zum Zitat Garret S, Jenkinson T, Kennedy L et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291 Garret S, Jenkinson T, Kennedy L et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291
10.
Zurück zum Zitat Calin A, Garret S, Whitelock H, Kennedy LG et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285PubMed Calin A, Garret S, Whitelock H, Kennedy LG et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21(12):2281–2285PubMed
11.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21(9):1694–1698PubMed Jenkinson TR, Mallorie PA, Whitelock HC et al (1994) Defining spinal mobility in ankylosing spondylitis (AS). The bath AS metrology index. J Rheumatol 21(9):1694–1698PubMed
12.
Zurück zum Zitat Karatepe AG, Akkoc Y, Akar S, Kirazlı Y, Akkoc N (2005) The Turkish versions of the bath ankylosing spondylitis and Dougados functional indices: reliability and validity. Rheumatol Int 25(8):612–618. Epub 2004 Jul 10 Karatepe AG, Akkoc Y, Akar S, Kirazlı Y, Akkoc N (2005) The Turkish versions of the bath ankylosing spondylitis and Dougados functional indices: reliability and validity. Rheumatol Int 25(8):612–618. Epub 2004 Jul 10
13.
Zurück zum Zitat Akkoc Y, Karatepe AG, Akar S, Kirazlı Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280–284. Epub 2004 Jan 17 Akkoc Y, Karatepe AG, Akar S, Kirazlı Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25(4):280–284. Epub 2004 Jan 17
14.
Zurück zum Zitat Averns HL, Oxtoby J, Taylor HG, Jones PW et al (1996) Radiological outcome in ankylosing spondylitis: use of the stoke ankylosing spondylitis spine score(SASSS). Br J Rheumatol 35:373–376PubMedCrossRef Averns HL, Oxtoby J, Taylor HG, Jones PW et al (1996) Radiological outcome in ankylosing spondylitis: use of the stoke ankylosing spondylitis spine score(SASSS). Br J Rheumatol 35:373–376PubMedCrossRef
15.
Zurück zum Zitat Dawes PT, Sheeran TP, Beswick EJ, Hothersall TE (1987) Enthesopathy index in ankylosing spondylitis. Ann Rheum Dis 46:717PubMed Dawes PT, Sheeran TP, Beswick EJ, Hothersall TE (1987) Enthesopathy index in ankylosing spondylitis. Ann Rheum Dis 46:717PubMed
16.
Zurück zum Zitat Balint PV, Kane D, Wilson H et al (2002) Ultrasonography of enthesal insertions in the lower limb in spondylarthropathy. Ann Rheum Dis 61(10):905–910PubMedCrossRef Balint PV, Kane D, Wilson H et al (2002) Ultrasonography of enthesal insertions in the lower limb in spondylarthropathy. Ann Rheum Dis 61(10):905–910PubMedCrossRef
17.
Zurück zum Zitat Yildirim K, Erdal A, Karatay S et al (2004) Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with Ankylosing Spondylitis. South Med J 97(4):350–353PubMedCrossRef Yildirim K, Erdal A, Karatay S et al (2004) Relationship between some acute phase reactants and the Bath Ankylosing Spondylitis Disease Activity Index in patients with Ankylosing Spondylitis. South Med J 97(4):350–353PubMedCrossRef
18.
Zurück zum Zitat Taylor HG, Wardle T, Beswick EJ et al (1991) The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 30(5):330–335PubMedCrossRef Taylor HG, Wardle T, Beswick EJ et al (1991) The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis. Br J Rheumatol 30(5):330–335PubMedCrossRef
19.
Zurück zum Zitat Spoorenberg A, van der Heijde D, de Klerk E, Dougados M et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980–984PubMed Spoorenberg A, van der Heijde D, de Klerk E, Dougados M et al (1999) Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 26(4):980–984PubMed
20.
Zurück zum Zitat Laurent MR, Panayi GS (1983) Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 42:524–528PubMedCrossRef Laurent MR, Panayi GS (1983) Acute-phase proteins and serum immunoglobulins in ankylosing spondylitis. Ann Rheum Dis 42:524–528PubMedCrossRef
21.
Zurück zum Zitat Sheenan NJ, Slavin BM, Donovan MP, Mount JN, Mathews JA (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase protein or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 25:171–174CrossRef Sheenan NJ, Slavin BM, Donovan MP, Mount JN, Mathews JA (1986) Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase protein or protease inhibitors in ankylosing spondylitis. Br J Rheumatol 25:171–174CrossRef
22.
Zurück zum Zitat van Tubergen A, van der Heijde D, Anderson J et al (2003) Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis 62(3):215–221PubMedCrossRef van Tubergen A, van der Heijde D, Anderson J et al (2003) Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis 62(3):215–221PubMedCrossRef
23.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG, Whitelock H et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spodylitis Disease Activity Index. J Rheumatol 21(12):2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spodylitis Disease Activity Index. J Rheumatol 21(12):2286–2291PubMed
24.
Zurück zum Zitat Spoorenber A, van Tubergen A, Landewe R, Dougados M, van der Linden S, Mielants H, van de Tempel H, van der Heijde D (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 44:789–95CrossRef Spoorenber A, van Tubergen A, Landewe R, Dougados M, van der Linden S, Mielants H, van de Tempel H, van der Heijde D (2005) Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology (Oxford) 44:789–95CrossRef
25.
Zurück zum Zitat Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D (2004) The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 51(2):154–159PubMedCrossRef Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, Landewe R, Dougados M, Mielants H, van der Tempel H, van der Heijde D (2004) The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum 51(2):154–159PubMedCrossRef
Metadaten
Titel
Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis
verfasst von
Taciser Kaya
Serpil Bal
Rezzan Gunaydin
Publikationsdatum
01.02.2007
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 4/2007
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0218-0

Weitere Artikel der Ausgabe 4/2007

Rheumatology International 4/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.